
Sign up to save your podcasts
Or


“For nuclear medicine to be widely successful you have to care about people everywhere. We need to come up with solutions that make nuclear medicine really accessible for everyone. And the reason why we should do that is because it has a great cost beneficial profile”. The serial entrepreneur Dr Christian Behrenbruch is co-founder and CEO of Telix Pharmaceuticals and our guest in this episode of Theragnostic Talks. Enjoy!
Guest: Dr Christian Behrenbruch
What does the future look like for more personalized therapy? And is sometimes no treatment the best option? In this episode we continue talking to professor Rodney Hicks, director of molecular imaging at the Peter MacCallum Cancer Centre and professor of medicine and radiology at the University of Melbourne. For Rodney Hicks, it's all about the patient. In a time when science focus on overall survival – he asks: what quality of life does it bring to the patient?
Guest: Rodney Hicks
He is known as a pioneer, has over 500 peer-reviewed publications and has held numerous national and international research grants. Professor Rodney Hicks is our first guest on Theragnostic Talks, a podcast by SAM Nordic. He is director of molecular imaging at the Peter MacCallum Cancer Centre and professor of medicine and radiology at the University of Melbourne. In this episode Rodney Hicks talks about why imaging is important, why he attends at his patients funerals and why the treatment isn't science, but art.
Guest: Rodney Hicks
How can theragnostic be a part of tomorrow's cancer care? How can industry, academia and healthcare cooperate in a successful way? And what is the next step, what is waiting around the corner?
In our podcast Theragnostic Talks we will we talk to true experts from around the world. We will find out interesting science and get answers to our curious questions. Enjoy!
By: Gustav Widar and Annette Andrén
From the publisher's feed